Episode 164
AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery
April 30, 202517m 58s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Discover how AI and biotech are joining forces to transform drug development—from genomics and CRISPR target validation to machine learning–driven compound design and high-throughput screening. In this episode of TechDaily.AI (brought to you by StoneFly), we cover:
- Omics Insights: Mining genomics, transcriptomics, proteomics & metabolomics to pinpoint targets
- Gene Editing: Using CRISPR and CAR-T engineering for precision therapies
- AI in Drug Design: Leveraging ML/DL for toxicity prediction, ADME modeling & de novo molecule generation
- Automation & Scale: High-throughput assays, synthetic biology platforms (e.g., engineered yeast)
- Clinical Acceleration: AI-powered patient matching for faster trials
- Roadmap & Challenges: Data quality, explainable AI, vendor collaboration & regulatory readiness
Tune in to learn how this synergy is cutting R&D costs, speeding timelines, and paving the way for personalized medicine.
Topics
aibiologyAI drug discoverybiotech AIgenomics machine learningCRISPR therapeuticsproteomics AImetabolomics analyticshigh-throughput screeningsynthetic biologyde novo drug designpharmacogenomicsprecision medicineexplainable AIclinical trial AIdrug repurposing